Unmet Needs in R/R Follicular Lymphoma (FL)
FL is a chronic and incurable disease that typically responds to first-line treatment but inevitably relapses.
Prospective Registry to Assess Long-Term Safety or Tisagenlecleucel in Patients With B-Cell Malignancies
Study of Tisagenlecleucel in 1L HR Pediatric and Young-Adult Patients with B-ALL Who Are MRD Positive at the EOC Therapy
ALL, CLL, DLBCL, SLL
CD19-Specific CAR-T Cells (YTB323) in Adult Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Diffuse Large B-Cell Lymphoma
BCMA-directed CAR-T Cells in adults with R/R MM
CD19-targeted CAR-T cell therapy
CAR-T = chimeric antigen receptor T-cell.
This site may contain information of products which have not been authorized in your country.
Please note that the following content is exclusively addressed to healthcare professionals and its correct interpretation requires specialized training.
Are you a healthcare professional?